Nizhniy Novgorod regional clinical oncological dispensary ( Site 1169)

Nizhny Novgorod, Nizhny Novgorod Oblast 603126

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Squamous Cell

Studies at this site

• Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630) — Completed